The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 131, Issue 3, Pages 752-759
Publisher
Wiley
Online
2011-09-13
DOI
10.1002/ijc.26421
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells
- (2011) Alejandro Vazquez-Martin et al. CELL CYCLE
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
- (2010) I. Ben Sahra et al. CANCER RESEARCH
- Genome-wide inhibitory impact of the AMPK activator metformin on [kinesins, tubulins, histones, aurorasandpolo-like kinases] M-phase cell cycle genes in human breast cancer cells
- (2010) Cristina Oliveras-Ferraros et al. CELL CYCLE
- Crosstalk between Insulin/Insulin-like Growth Factor-1 Receptors and G Protein-Coupled Receptor Signaling Systems: A Novel Target for the Antidiabetic Drug Metformin in Pancreatic Cancer
- (2010) E. Rozengurt et al. CLINICAL CANCER RESEARCH
- Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure
- (2010) S. L. Bowker et al. DIABETOLOGIA
- Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase
- (2010) Carolyn Algire et al. ENDOCRINE-RELATED CANCER
- Prospective Study Reveals Associations Between Colorectal Cancer and Type 2 Diabetes Mellitus or Insulin Use in Men
- (2010) Peter T. Campbell et al. GASTROENTEROLOGY
- Mechanisms by which thiazolidinediones induce anti-cancer effects in cancers in digestive organs
- (2010) Toshikatsu Okumura JOURNAL OF GASTROENTEROLOGY
- Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase
- (2010) Kunihiro Hosono et al. MOLECULAR CARCINOGENESIS
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Insulin resistance and hyperinsulinaemia in the development and progression of cancer
- (2009) Ian F. Godsland CLINICAL SCIENCE
- Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
- (2009) G. W.D. Landman et al. DIABETES CARE
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- (2009) C. J. Currie et al. DIABETOLOGIA
- Colorectal Cancer Outcomes, Recurrence, and Complications in Persons With and Without Diabetes Mellitus: A Systematic Review and Meta-Analysis
- (2009) Kelly B. Stein et al. DIGESTIVE DISEASES AND SCIENCES
- Metformin in chemically-induced mammary carcinogenesis in rats
- (2009) B. Bojkova et al. NEOPLASMA
- Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model
- (2008) Kathryn N. Phoenix et al. BREAST CANCER RESEARCH AND TREATMENT
- Metformin suppresses intestinal polyp growth in ApcMin/+ mice
- (2008) Ayako Tomimoto et al. CANCER SCIENCE
- Type 2 diabetes mellitus as risk factor for colorectal cancer
- (2008) Jutta M. Berster et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation